We have previously demonstrated that the growth factor EGF induces HER2 protein expression in primary breast cultures derived from patient tumours, thus implicating an activated MAPK pathway in HER2 transcriptional regulation (Myers et al, 2005). The gene discussed is EGF; the disease is neoplasm.